Chemical Structure : TCV-309 chloride
CAS No.: 121494-09-5
Catalog No.: PC-45596Not For Human Use, Lab Use Only.
TCV-309 chloride is a highly potent and selective platelet activating factor (PAF) antagonist, inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $238 | In stock | |
| 10 mg | $378 | In stock | |
| 25 mg | $598 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TCV-309 chloride is a highly potent and selective platelet activating factor (PAF) antagonist, inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively.
TCV-309 potently protects mice from death induced by PAF and due to anaphylactic shock with ED50 of 2.1 and 2.6 ug/kg (i.v.), respectively.
TCV-309 also reverses PAF-induced hypotension and endotoxin-induced hypotension in rats.
| M.Wt | 629.9724 | |
| Formula | C30H34BrClN4O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
DMSO: ≥ 6.3 mg/mL |
|
| Chemical Name/SMILES |
Pyridinium, 3-bromo-5-[[[3-[[2-[[(3,4-dihydro-2(1H)-isoquinolinyl)carbonyl]oxy]ethyl]amino]-3-oxopropyl]phenylamino]carbonyl]-1-propyl-, chloride (1:1) |
|
1. Terashita Z, et al. J Pharmacol Exp Ther. 1992 Feb;260(2):748-55.
2. Motoyama N, et al. Eur J Pain. 2013 Sep;17(8):1156-67.
3. Kuipers B, et al. J Immunol. 1994 Mar 1;152(5):2438-46.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright